Simplex Trading’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,063
| Closed | -$1K | – | 2869 |
|
|
2025
Q1 | $1K | Sell |
1,063
-2,303
| -68% | -$2.17K | ﹤0.01% | 2175 |
|
|
2024
Q4 | $3K | Buy |
+3,366
| New | +$3K | ﹤0.01% | 2106 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2738 |
|
|
2024
Q2 | – | Sell |
-18,261
| Closed | -$69K | – | 2837 |
|
|
2024
Q1 | $69K | Buy |
+18,261
| New | +$69K | ﹤0.01% | 1314 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2855 |
|
|
2023
Q3 | – | Sell |
-12,675
| Closed | -$33K | – | 2759 |
|
|
2023
Q2 | $33K | Sell |
12,675
-38
| -0.3% | -$99 | ﹤0.01% | 1382 |
|
|
2023
Q1 | $46K | Buy |
12,713
+4,560
| +56% | +$16.5K | ﹤0.01% | 1261 |
|
|
2022
Q4 | $31K | Buy |
8,153
+3,027
| +59% | +$11.5K | ﹤0.01% | 1457 |
|
|
2022
Q3 | $21K | Buy |
5,126
+821
| +19% | +$3.36K | ﹤0.01% | 1715 |
|
|
2022
Q2 | $19K | Buy |
+4,305
| New | +$19K | ﹤0.01% | 1782 |
|
|
2022
Q1 | – | Sell |
-10,164
| Closed | -$63K | – | 3251 |
|
|
2021
Q4 | $63K | Buy |
+10,164
| New | +$63K | ﹤0.01% | 1751 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3048 |
|
|
2021
Q2 | – | Sell |
-8,285
| Closed | -$91K | – | 3109 |
|
|
2021
Q1 | $91K | Buy |
8,285
+6,897
| +497% | +$75.8K | ﹤0.01% | 1471 |
|
|
2020
Q4 | $11K | Buy |
+1,388
| New | +$11K | ﹤0.01% | 1914 |
|